CKD staging and monitoring
Revise eGFR, ACR categories, repeat testing, blood pressure targets, CVD risk reduction, ACEi or ARB use, SGLT2 inhibitor indications and referral thresholds.
Renal and urology questions are threshold-heavy: whether an eGFR or ACR needs action, whether a medicine should be paused, whether haematuria is safe to repeat, and when urinary symptoms point to cancer, obstruction or infection.
For AKT renal and urology revision, prioritise CKD staging, eGFR, ACR, AKI, medication safety, UTI, pyelonephritis, haematuria, LUTS, PSA counselling, renal stones, acute urinary retention and urgent urology referral red flags.
Revise eGFR, ACR categories, repeat testing, blood pressure targets, CVD risk reduction, ACEi or ARB use, SGLT2 inhibitor indications and referral thresholds.
Know the AKI clues in primary care: acute illness, dehydration, NSAIDs, ACEi or ARBs, diuretics, metformin, contrast exposure and when urgent same-day assessment is needed.
Separate lower UTI, recurrent UTI, pregnancy, men, catheter-associated infection and pyelonephritis. The AKT often tests culture, antibiotic choice and escalation.
Focus on visible versus non-visible haematuria, proteinuria, infection, age thresholds, bladder or renal cancer referral and when repeat urine testing is not enough.
Revise storage and voiding symptoms, IPSS, DRE, PSA counselling, prostatitis, BPH medicines and suspected prostate cancer referral signals.
Know renal colic, CT KUB, NSAID analgesia, infection with obstruction, single kidney risk, bilateral obstruction and acute urinary retention management.
The trap is usually not obscure nephrology. It is deciding what the result means today: repeat, monitor, stop a risky medicine, refer for cancer, treat infection, or escalate because the patient may have AKI, obstruction or sepsis.
Yes. The RCGP renal and urology topic includes CKD monitoring, AKI, UTI, haematuria, urinary retention, LUTS, prostate disease, renal stones, testicular pathology and urological cancer referral thresholds.
Prioritise CKD staging with eGFR and ACR, blood pressure and CVD risk, ACEi or ARB monitoring, SGLT2 inhibitor indications, AKI recognition, medicine safety, renal referral thresholds and hyperkalaemia risk.
Haematuria questions usually test visible versus non-visible haematuria, age and cancer-risk thresholds, infection, proteinuria suggesting renal disease, and whether referral or repeat testing is the safest next step.
Know when urine culture is needed, how pregnancy, men, recurrent infection, catheters and pyelonephritis change management, and when red flags mean same-day assessment rather than routine antibiotics.
This is revision guidance, not official RCGP advice. Check current RCGP, NICE CKS and BNF guidance for clinical decisions. Last reviewed June 2026.
Questions, mocks and explanations are free. Your first 2 hours of AKT audio are free. Full 4-month audio access is £79.